Search Results - Ruth Farmer
- Showing 1 - 12 results of 12
-
1
-
2
-
3
Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models by Ruth Farmer, Deborah Ford, Rohini Mathur, Nish Chaturvedi, Richard Kaplan, Liam Smeeth, Krishnan Bhaskaran
Published 2019Artigo -
4
-
5
-
6
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review by Anthony Matthews, Susannah Stanway, Ruth Farmer, Helen Strongman, Sara Thomas, Alexander R. Lyon, Liam Smeeth, Krishnan Bhaskaran
Published 2018Revisão -
7
Risk of 16 cancers across the full glycemic spectrum: a population-based cohort study using the UK Biobank by Christopher T. Rentsch, Ruth Farmer, Sophie V. Eastwood, Rohini Mathur, Victoria Garfield, Aliki‐Eleni Farmaki, Krishnan Bhaskaran, Nish Chaturvedi, Liam Smeeth
Published 2020Artigo -
8
Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: A Descriptive Analysis in the UK CPRD by Ruth Farmer, Ivan Beard, Syed Raza, Nicholas D. Gollop, N. Patel, Abigail Tebboth, Andrew McGovern, Naresh Kanumilli, Andrew Ternouth
Published 2021Artigo -
9
Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank by Ruth Farmer, Rohini Mathur, Amand F. Schmidt, Krishnan Bhaskaran, Ghazaleh Fatemifar, Sophie V. Eastwood, Chris Finan, Spiros Denaxas, Liam Smeeth, Nish Chaturvedi
Published 2019Artigo -
10
Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression by Andreas Weiss, Ulrike Träger, Edward J. Wild, Stephan Grueninger, Ruth Farmer, Christian Landles, Rachael I. Scahill, Nayana Lahiri, Salman Haider, Douglas Macdonald, Chris Frost, Gillian P. Bates, Graeme Bilbe, Rainer Kühn, Ralph André, Sarah J. Tabrizi
Published 2012Artigo -
11
An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease by Sigurd D. Süßmuth, Salman Haider, G. Bernhard Landwehrmeyer, Ruth Farmer, Chris Frost, G Tripepi, Claus A. Andersen, Marco Di Bacco, Claudia Lamanna, Enrica Diodato, Luisa Massai, Daniela Diamanti, Elisa Mori, Letizia Magnoni, Jens Dreyhaupt, Karin Schiefele, David Craufurd, Carsten Saft, Monika Rudzińska, Danuta Ryglewicz, Michael Orth, Sebastian Brzozy, Anna Baran, Giuseppe Pollio, Ralph André, Sarah J. Tabrizi, Börje Darpö, Göran Westerberg
Published 2014Artigo -
12
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients by Luisa Quinti, Sharadha Dayalan Naidu, Ulrike Träger, Xiqun Chen, Kimberly B. Kegel-Gleason, David Llères, Colúm Connolly, Vanita Chopra, Cho Low, S. Moniot, Ellen Sapp, Adelaide Tousley, Petr Vodička, Michael J. Van Kanegan, Linda S. Kaltenbach, Lisa A. Crawford, Matthew Fuszard, Maureen Higgins, James R. C. Miller, Ruth Farmer, Vijay Potluri, Susanta Samajdar, Lisa Meisel, Ningzhe Zhang, Andrew R. Snyder, Ross L. Stein, Steven M. Hersch, Lisa Ellerby, Eranthie Weerapana, Michael A. Schwarzschild, Clemens Steegborn, Blair R. Leavitt, Alexei Degterev, Sarah J. Tabrizi, Donald C. Lo, Marian DiFiglia, Leslie M. Thompson, Albena T. Dinkova‐Kostova, Aleksey Kazantsev
Published 2017Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Cancer
Oncology
Type 2 diabetes
Cohort
Confidence interval
Confounding
Disease
Immunology
Biochemistry
Biology
Body mass index
Cohort study
Metformin
Breast cancer
Chemistry
Environmental health
Gene
Hazard ratio
Huntingtin
Huntington's disease
Immune system
Insulin
Intensive care medicine
Observational study
Pathology
Physical therapy